Results 221 to 230 of about 340,254 (355)
Studies on the Coagulation of Chicken Blood. I. Factors which Limit Plasma Coagulation Rate during Vitamin K Deficiency and Treatment with Coumarin Drugs. [PDF]
Øyvind Sørbye +4 more
openalex +1 more source
Microvascular Health as a Key Determinant of Organismal Aging
This review spotlights the emerging field of vascular aging, providing a comprehensive and critical overview of the molecular processes and clinical manifestations of vascular dysfunction during aging. By combining basic angioscience concepts with a critical analysis of innovative pre‐clinical aging models and lifestyle interventions, it offers a ...
Mattia Cenciarini +4 more
wiley +1 more source
The Role of Sterile Inflammation in Thrombosis: Consequences for Cardiovascular Disease and COVID-19. [PDF]
Khan GA +4 more
europepmc +1 more source
A novel melanin‐based therapeutic composed of ultrasmall polydopamine nanodots is employed as an efficient oral formulation for the targeted treatment of inflammatory bowel disease. The potential therapeutic mechanism of polydopamine nanodots mainly involves the elimination of excessive oxidative stress, the reduction of ROS‐mediated proinflammatory ...
Zhen Ding +11 more
wiley +1 more source
The impact of storage time on coagulation factor activity in FFP. [PDF]
Gao J +11 more
europepmc +1 more source
HLA alloimmunization and blood requirements in orthotopic liver transplantation. [PDF]
Duquesnoy, R +5 more
core
A biomimetic self‐assembly strategy, Procyanidin Capsules (PC‐Ca), has been developed, which has great stability, bioavailability, and liver‐targeting efficacy and modulates the KEAP1‐NRF2 axis to inhibit ROS formation and necroptosis, regulate mitochondrial homeostasis through the PGAM5/DRP1/PINK1 signaling pathway in thioacetamide (TAA)‐induced ALF ...
Qing Shi +8 more
wiley +1 more source
The clot thickens: transverse cables under high shear flow. [PDF]
Kreinin Y, Korin N.
europepmc +1 more source
Preparation of a biopolymer‐based immune implant (BI) for the sustained release of R848 and oxaliplatin (OXA), enabling immune activation and preventing recurrence after radiofrequency ablation (RFA) treatment in hepatocellular carcinoma (HCC). Abstract Hepatocellular carcinoma (HCC) remains a global challenge due to limited therapies and high ...
Yuezhan Shan +9 more
wiley +1 more source

